A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer

被引：0
作者：
Takuro Kainuma
Shogo Kawakami
Hideyasu Tsumura
Takefumi Satoh
Ken-ichi Tabata
Masatsugu Iwamura
Kazushige Hayakawa
Hiromichi Ishiyama
机构：
[1] Kitasato University School of Medicine,Department of Radiation Oncology
[2] Kitasato University School of Medicine,Department of Urology
来源：
Radiation Oncology | / 14卷
关键词：
Prostate cancer; Stereotactic body radiotherapy; Dose-escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial
    Al-Mamgani, Abrahim
    Heemsbergen, Wilma D.
    Levendag, Peter C.
    Lebesque, Joos V.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 (01) : 13 - 18
  • [32] Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial
    Storey, MR
    Pollack, A
    Zagars, G
    Smith, L
    Antolak, J
    Rosen, I
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 635 - 642
  • [33] Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study
    Hirata, Takero
    Suzuki, Osamu
    Otani, Keisuke
    Miyake, Akimitsu
    Tamari, Keisuke
    Seo, Yuji
    Isohashi, Fumiaki
    Kai, Naoki
    Hatano, Koji
    Fujita, Kazutoshi
    Uemura, Motohide
    Imamura, Ryoichi
    Tamenaga, Setsuo
    Yoshino, Yutaro
    Fumimoto, Yasutoshi
    Yoshioka, Yasuo
    Nonomura, Norio
    Ogawa, Kazuhiko
    ACTA ONCOLOGICA, 2023, 62 (05) : 488 - 494
  • [34] Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study
    Rooney, K. P.
    Miah, A. B.
    Bhide, S. A.
    Guerrero-Urbano, M. T.
    Sharabiani, M. T.
    Newbold, K. L.
    Grove, L.
    Harrington, K. J.
    Nutting, C. M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (01) : 43 - 48
  • [35] Clinical outcome of stereotactic body radiotherapy for localized prostate cancer: long-term results
    Kim, H. J.
    Lee, J. S.
    Kim, W. C.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2020, 18 (03): : 383 - 388
  • [36] Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
    Ma, Ting Martin
    Lilleby, Oscar
    Lilleby, Wolfgang A.
    Kishan, Amar U.
    CANCERS, 2020, 12 (12) : 1 - 20
  • [37] Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy
    Raziee, Hamid
    Moraes, Fabio Y.
    Murgic, Jure
    Chua, Melvin L. K.
    Pintilie, Melania
    Chung, Peter
    Menard, Cynthia
    Bayley, Andrew
    Gospodarowicz, Mary
    Warde, Padraig
    Craig, Tim
    Catton, Charles
    Bristow, Robert G.
    Jaffray, David A.
    Berlin, Alejandro
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (03) : 459 - 465
  • [38] Stereotactic body radiotherapy for multisite extracranial oligometastases Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
    Salama, Joseph K.
    Hasselle, Michael D.
    Chmura, Steven J.
    Malik, Renuka
    Mehta, Neil
    Yenice, Kamil M.
    Villaflor, Victoria M.
    Stadler, Walter M.
    Hoffman, Philip C.
    Cohen, Ezra E. W.
    Connell, Philip P.
    Haraf, Daniel J.
    Vokes, Everett E.
    Hellman, Samuel
    Weichselbaum, Ralph R.
    CANCER, 2012, 118 (11) : 2962 - 2970
  • [39] A bayesian approach for dose-escalation in a phase I clinical trial incorporating pharmacodynamic endpoints
    Whitehead, John
    Zhou, Yinghui
    Hampson, Lisa
    Ledent, Edouard
    Pereira, Alvaro
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (06) : 1117 - 1129
  • [40] The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?
    Wee Loon Ong
    Andrew Loblaw
    World Journal of Urology, 2023, 41 : 3485 - 3491
12345